These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2406873)

  • 1. Antimicrobial susceptibility testing of anaerobic bacteria: review and update on the role of the National Committee for Clinical Laboratory Standards.
    Thornsberry C
    Rev Infect Dis; 1990; 12 Suppl 2():S218-22. PubMed ID: 2406873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN; Barry AL; Fuchs PC; Allen SD
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Clin Lab Med; 1989 Jun; 9(2):239-54. PubMed ID: 2659243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing (AST): a review of changing trends, quality control guidelines, test accuracy, and recommendation for the testing of beta-lactam drugs.
    Jones RN
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):1-24. PubMed ID: 6368105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards.
    Barry AL; Fuchs PC; Allen SD; Thornsberry C; Gerlach EH; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):192-5. PubMed ID: 2643622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for susceptibility testing of anaerobic bacteria.
    Olsson-Liljequist B; Nord CE
    Clin Infect Dis; 1994 May; 18 Suppl 4():S293-6. PubMed ID: 8086578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
    Zabransky RJ; Bobey DG; Barry AL; Allen SD; Fuchs PC; Gerlach EH; Thornsberry C; Sheikh W; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):190-1. PubMed ID: 2643621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.
    Zabransky RJ; Bayola-Mueller L; Jenkins SG; Pitkin DR; Schreckenberger PC; Celig DM; Spiegel CA
    J Clin Microbiol; 1990 Dec; 28(12):2804-5. PubMed ID: 2280013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of anaerobe susceptibility testing in the United States.
    Hecht DW
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S28-35. PubMed ID: 12173105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NCCLS in antimicrobial susceptibility testing and monitoring.
    Ginocchio CC
    Am J Health Syst Pharm; 2002 Apr; 59(8 Suppl 3):S7-11. PubMed ID: 11977864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
    Schuetz AN
    Clin Infect Dis; 2014 Sep; 59(5):698-705. PubMed ID: 24867792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing of anaerobic bacteria--the state of the art.
    Wexler HM
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S328-33. PubMed ID: 8324142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of methods for susceptibility testing of anaerobes.
    Zabransky RJ
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1025-31. PubMed ID: 1295756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria.
    Barry AL; Fuchs PC; Gerlach EH; Allen SD; Acar JF; Aldridge KE; Bourgault AM; Grimm H; Hall GS; Heizmann W
    Rev Infect Dis; 1990; 12 Suppl 2():S210-7. PubMed ID: 2406872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans/ Anaerobic Subcommittee of the Asociación Argentina de Microbiología].
    Legaria MC; Bianchini HM; Castello L; Carloni G; Di Martino A; Fernández Canigia L; Litterio M; Rollet R; Rossetti A; Predari SC
    Rev Argent Microbiol; 2011; 43(1):51-66. PubMed ID: 21491069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing of anaerobic bacteria: myth, magic, or method?
    Wexler HM
    Clin Microbiol Rev; 1991 Oct; 4(4):470-84. PubMed ID: 1747863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method (2007).
    Nagayama A; Yamaguchi K; Watanabe K; Tanaka M; Kobayashi I; Nagasawa Z
    J Infect Chemother; 2008 Oct; 14(5):383-92. PubMed ID: 18936894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.